(Q40484574)

20 September 2017

Alternative phospholipase D/mTOR survival signal in human breast cancer cells (English)

1 reference

20 September 2017

Yuhong Chen

1

1 reference

20 September 2017

Vanessa Rodrik

series ordinal

2

1 reference

20 September 2017

David A Foster

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

4

1 reference

20 September 2017

672-679

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208099

20 September 2017

0 references

cites work

Transmodulation between Phospholipase D and c-Src Enhances Cell Proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phospholipase D confers rapamycin resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Regulation of phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Ras mediates the activation of phospholipase D by v-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Involvement of Ral GTPase in v-Src-induced phospholipase D activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Akt regulates growth by directly phosphorylating Tsc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Does the ribosome translate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

ARF proteins mediate insulin-dependent activation of phospholipase D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

Increased phospholipase D activity in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased activity and intranuclear expression of phospholipase D2 in human renal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208099

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208099

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference